newsPembrolizumab plus chemo improves endometrial cancer survival3 February 2023 | By Catherine Eckford (European Pharmaceutical Review)An interim analysis of a Phase III trial showed pembrolizumab plus chemotherapy significantly improved survival in endometrial cancer.